Ignite Creation Date:
2024-05-19 @ 5:33 PM
Last Modification Date:
2024-10-26 @ 3:30 PM
Study NCT ID:
NCT06419621
Status:
RECRUITING
Last Update Posted:
2024-05-28
First Post:
2024-05-14
Brief Title:
PM8002 or Placebo Plus Nab-Paclitaxel as First-line Treatment in Inoperable Locally AdvancedMetastatic Triple-negative Breast Cancer
Sponsor:
Biotheus Inc
Organization:
Biotheus Inc
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-06
Start Date Type:
ESTIMATED
Primary Completion Date:
2027-07
Primary Completion Date Type:
ESTIMATED
Completion Date:
2028-07
Completion Date Type:
ESTIMATED
First Submit Date:
2024-05-14
First Submit QC Date:
May 14 2024
Study First Post Date:
2024-05-17
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-07-19
Last Update Post Date:
2024-05-28
Last Update Post Date Type:
ACTUAL